Mometasonfuroat Aristo Pharma (Mometasone Furoate Ph. Eur.)

Mometasone furoate, the active ingredient in Mometasonfuroat Aristo Pharma, is a corticosteroid presented as a nasal spray for nasal administration. It is used to reduce inflammation in the nasal passages of patients with allergic rhinitis or nasal polyps. It is formulated according to the European Pharmacopoeia specifications and is intended for adult and adolescent patients.

GNH USA supplies Mometasonfuroat Aristo Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Mometasone furoate, a nasal corticosteroid, acts on inflammatory pathways of the nasal mucosa to relieve symptoms.

- Allergic rhinitis: reduces nasal congestion, itching and sneezing by decreasing mucosal inflammation. - Nasal polyps: shrinks polyp size and improves nasal airflow through anti‑inflammatory action. - Seasonal allergic rhinitis: alleviates seasonal symptom flare‑ups by controlling nasal inflammation.

Mometasone furoate nasal spray may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Altered taste or throat irritation

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Adrenal suppression with prolonged high‑dose use

When prescribing Mometasone furoate nasal spray, clinicians should consider several safety measures.

- Assess for active nasal infection: avoid use until infection resolved. - Avoid in patients with known hypersensitivity to mometasone or formulation excipients. - Use the lowest effective dose: limit duration to recommended period. - Monitor for signs of adrenal suppression: especially with long‑term or high‑dose therapy. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Mometasone furoate nasal spray can interact with other medications, affecting its safety or efficacy.

Major Interactions (Avoid): - Concurrent systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic exposure.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase local irritation. - Nasal decongestants: combined use can cause excessive dryness. - Immunosuppressants: monitor for additive immunosuppression.